MBD2 promotes epithelial-to-mesenchymal transition (EMT) and ARDS-related pulmonary fibrosis by modulating FZD2
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025-06 · 1871 (5) · 167798
DOI: 10.1016/j.bbadis.2025.167798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025-06. Verfasst von Yang Zhou und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, The Second Xiangya Hospital of Central South University, Emergency and Difficult Diseases Institute of Central Sout…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Pulmonary Fibrosis, Respiratory Distress Syndrome, DNA-Binding Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Health Commission of Hunan Province, Natural Science Foundation of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
OBJECTIVE: To investigate the role and underlying mechanism of Methyl-CpG binding domain protein 2 (MBD2) in the pathogenesis of acute respiratory distress syndrome (ARDS)-related pulmonary fibrosis. METHODS: Murine models for ARDS-related pulmonary fibrosis were established in wildtype or MBD2 knockout mice, expressions of MBD2 were determined with immunohistochemistry (IHC), immunofluorescence, and western blot. Epithelial-to-mesenchymal transition (EMT) was detected with determined with decreased expression of E-cadherin and increased expressions of N-cadherin, Vimentin, and α-smooth muscle actin (α-SMA). Transforming growth factor β (TGF-β) treated mouse lung epithelial-12 (MLE-12) cells and primary human type II alveolar epithelial cells were applied to establish in vitro model for EMT. Transcriptional sequencing with RNA-Seq and Chromatin immunoprecipitation (ChIP) assay were used to explore the potential targets of MBD2. Single cell sequencing data and Human pulmonary fibrosis samples were analyzed. RESULTS: Bleomycin (BLM) and lipopolysaccharide (LPS) induced EMT, pulmonary fibrosis, and increased expression of MBD2 in alveolar epithelial cells of mice, and MBD2 knockout significantly alleviated BLM- and LPS-induced pulmonary fibrosis and EMT. TGF-β induced EMT and elevated MBD2 expressions in alveolar epithelial cells, which was mitigated by MBD2 knockdown and aggravated by MBD2 overexpression. Frizzled 2 (FZD2) was found to be the potential target of MBD2. Single-cell sequencing analysis of ARDS patients suggested elevated expression of MBD2 in alveolar epithelial cells, and MBD2 expression was elevated in the lungs of patients with pulmonary fibrosis. CONCLUSION: Our results indicated that MBD2 could promote EMT and ARDS-related pulmonary fibrosis, potentially by modulating the expression of FZD2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, The Second Xiangya Hospital of Central South University, Emergency and Difficult Diseases Institute of Central South University, Changsha, Hunan, China; Department of Critical Care Medi…
- Department of Emergency Medicine, The Second Xiangya Hospital of Central South University, Emergency and Difficult Diseases Institute of Central South University, Changsha, Hunan, China.
- Department of Orthopedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China; Department of Thoracic Surgery, Guilin Hospital of the Second Xiangya Hospital of Central South University…
- Department of Respiratory and Critical Care Medicine, Guilin Hospital of the Second Xiangya Hospital of Central South University, Guilin, Guangxi, China.
Förderung
- National Natural Science Foundation of China
- Health Commission of Hunan Province
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
- Hunan Provincial Natural Science Foundation
- Natural Science Foundation of Guangxi Province
- Changsha Science and Technology Bureau
Zitieren
APA
Zhou, Y., Yang, G., Liu, J., Yao, S., Jia, J., Tang, X., Gong, X., Wan, F., Wu, R., Zhao, Z., Liang, H., Liu, L., Liu, Q., Xie, S., Long, X., Xiang, X., Wang, G., & Xiao, B. (2025). MBD2 promotes epithelial-to-mesenchymal transition (EMT) and ARDS-related pulmonary fibrosis by modulating FZD2. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1871(5), 167798. https://doi.org/10.1016/j.bbadis.2025.167798
Vancouver
Zhou Y, Yang G, Liu J, Yao S, Jia J, Tang X, et al. MBD2 promotes epithelial-to-mesenchymal transition (EMT) and ARDS-related pulmonary fibrosis by modulating FZD2. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025;1871(5):167798. doi:10.1016/j.bbadis.2025.167798
BibTeX
@article{Zhou2025,
author = {Zhou, Yang and Yang, Guifang and Liu, Jiqiang and Yao, Shuo and Jia, Jingsi and Tang, Xianming and Gong, Xun and Wan, Fang and Wu, Ren and Zhao, Zhenyu and Liang, Hengxing and Liu, Linxia and Liu, Qimi and Xie, Shanshan and Long, Xian and Xiang, Xudong and Wang, Guyi and Xiao, Bing},
title = {MBD2 promotes epithelial-to-mesenchymal transition (EMT) and ARDS-related pulmonary fibrosis by modulating FZD2},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2025},
volume = {1871},
number = {5},
pages = {167798},
doi = {10.1016/j.bbadis.2025.167798}
}
EUVIMED